ATE394485T1 - Neue g protein-gekoppelte rezeptor proteine, dnas davon und liganden für diese - Google Patents
Neue g protein-gekoppelte rezeptor proteine, dnas davon und liganden für dieseInfo
- Publication number
- ATE394485T1 ATE394485T1 AT99949421T AT99949421T ATE394485T1 AT E394485 T1 ATE394485 T1 AT E394485T1 AT 99949421 T AT99949421 T AT 99949421T AT 99949421 T AT99949421 T AT 99949421T AT E394485 T1 ATE394485 T1 AT E394485T1
- Authority
- AT
- Austria
- Prior art keywords
- present
- protein
- coupled receptor
- ligand
- protein coupled
- Prior art date
Links
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 title abstract 10
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 title abstract 10
- 239000003446 ligand Substances 0.000 title abstract 10
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 150000003839 salts Chemical class 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000556 agonist Substances 0.000 abstract 3
- 102000005962 receptors Human genes 0.000 abstract 3
- 108020003175 receptors Proteins 0.000 abstract 3
- 238000012216 screening Methods 0.000 abstract 3
- 239000005557 antagonist Substances 0.000 abstract 2
- 210000004556 brain Anatomy 0.000 abstract 2
- 210000001638 cerebellum Anatomy 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 238000011002 quantification Methods 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30594998 | 1998-10-27 | ||
| JP2771099 | 1999-02-04 | ||
| JP5720799 | 1999-03-04 | ||
| JP27622599A JP4486187B2 (ja) | 1998-10-27 | 1999-09-29 | 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE394485T1 true ATE394485T1 (de) | 2008-05-15 |
Family
ID=27458743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99949421T ATE394485T1 (de) | 1998-10-27 | 1999-10-26 | Neue g protein-gekoppelte rezeptor proteine, dnas davon und liganden für diese |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US6699965B1 (de) |
| EP (1) | EP1126028B1 (de) |
| JP (1) | JP4486187B2 (de) |
| KR (1) | KR20010085974A (de) |
| CN (1) | CN1324405A (de) |
| AT (1) | ATE394485T1 (de) |
| AU (1) | AU6230699A (de) |
| BR (1) | BR9914835A (de) |
| CA (1) | CA2347294A1 (de) |
| CZ (1) | CZ20011358A3 (de) |
| DE (1) | DE69938666D1 (de) |
| HU (1) | HUP0104937A2 (de) |
| ID (1) | ID28288A (de) |
| IL (1) | IL142428A0 (de) |
| NO (1) | NO20012059L (de) |
| NZ (1) | NZ510977A (de) |
| PL (1) | PL347553A1 (de) |
| SK (1) | SK5502001A3 (de) |
| WO (1) | WO2000024890A1 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000050563A2 (en) * | 1999-02-24 | 2000-08-31 | Merck & Co., Inc. | G protein-coupled receptor resembling galanin receptors |
| AU2001244609A1 (en) * | 2000-03-30 | 2001-10-15 | Takeda Chemical Industries Ltd. | Novel protein, dna thereof and process for producing the same |
| EP1168259A3 (de) | 2000-06-28 | 2003-12-17 | Hitachi, Ltd. | Datenverwaltungssystem und Verfahren für eine Chip-Karte |
| JP4762481B2 (ja) * | 2000-08-30 | 2011-08-31 | 株式会社セルフリーサイエンス | 無細胞タンパク質合成用転写鋳型の設計および構築、並びにこれを用いる希釈バッチ方式コムギ胚芽無細胞タンパク質合成法 |
| JP2002109169A (ja) | 2000-09-29 | 2002-04-12 | Hitachi Ltd | 作業支援方法並びにシステム及び作業支援方法を記録した記録媒体 |
| CA2430934C (en) | 2000-12-01 | 2011-06-21 | Takeda Chemical Industries, Ltd. | A method of producing sustained-release preparations of a bioactive substance using high-pressure gas |
| EP1363655A4 (de) * | 2000-12-18 | 2005-04-06 | Merck & Co Inc | Für einen g-protein-gekoppelten rezeptor - gpr 54 - aus mensch und maus codierende, isolierte nukleinsäuremoleküle, davon codierte proteine, damit transformierte zellen und verwendungen davon |
| WO2002057309A1 (fr) * | 2001-01-18 | 2002-07-25 | Takeda Chemical Industries, Ltd. | Nouvelle proteine receptrice couplee a la proteine g et adn de cette proteine |
| WO2002072816A1 (fr) * | 2001-02-26 | 2002-09-19 | Takeda Chemical Industries, Ltd. | Proteine de recepteur murin de type kiss-1 et adn correspondant |
| WO2002083735A1 (fr) * | 2001-04-06 | 2002-10-24 | Takeda Chemical Industries, Ltd. | Nouvelle proteine receptrice et son adn |
| JP2005536439A (ja) | 2001-09-18 | 2005-12-02 | ジェネンテック・インコーポレーテッド | 腫瘍の診断及び治療のための組成物と方法 |
| AU2008202007B2 (en) * | 2001-09-18 | 2010-12-16 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| WO2003027149A1 (fr) * | 2001-09-19 | 2003-04-03 | Takeda Chemical Industries, Ltd. | Anticorps et utilisation de ce dernier |
| CA2472423A1 (en) * | 2002-01-11 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Process for producing kiss-1 peptide |
| EP1578373A4 (de) * | 2002-09-11 | 2007-10-24 | Genentech Inc | Neue zusammensetzungen und verfahren zur behandlung von erkrankungen des immunsystems |
| CN1761680A (zh) | 2002-12-26 | 2006-04-19 | 武田药品工业株式会社 | 肿瘤迁移抑制素衍生物及其用途 |
| US6800611B2 (en) | 2003-01-06 | 2004-10-05 | Takeda Chemical Industries, Ltd. | Metastin derivatives and their use |
| WO2004080479A1 (ja) * | 2003-03-12 | 2004-09-23 | Takeda Pharmaceutical Company Limited | 性腺機能改善剤 |
| JP4639052B2 (ja) * | 2003-03-12 | 2011-02-23 | 武田薬品工業株式会社 | 性腺機能改善剤 |
| EP1464652A1 (de) * | 2003-04-02 | 2004-10-06 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | GPR54 Rezeptor-Agonist oder -Antagonist verwendbar zur Behandlung von gonadotropin-assoziierten Krankheiten |
| AU2004234399A1 (en) * | 2003-04-28 | 2004-11-11 | Wyeth | Methods utilising G-protein coupled receptor 54 |
| WO2004101747A2 (en) * | 2003-05-07 | 2004-11-25 | The General Hospital Corporation | Identification and use of gpr54 and its ligands for reproductive disorders and contraception |
| WO2005040833A1 (en) * | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Regulation of human metastin recognising receptors |
| PE20060371A1 (es) | 2004-06-25 | 2006-06-15 | Takeda Pharmaceutical | Derivados de metastina en el tratamiento del cancer |
| US20090099334A1 (en) * | 2005-12-22 | 2009-04-16 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| AR058584A1 (es) | 2005-12-22 | 2008-02-13 | Takeda Pharmaceutical | Derivados de metastina y uso de los mismos |
| US8404643B2 (en) * | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| ITMI20061607A1 (it) | 2006-08-09 | 2008-02-10 | Maria Vincenza Carriero | Peptidi con attivita farmacologica |
| JO3048B1 (ar) * | 2006-10-25 | 2016-09-05 | Takeda Pharmaceuticals Co | مشتقات متاستين واستخدامها |
| EP2277900A4 (de) * | 2008-04-24 | 2011-08-03 | Takeda Pharmaceutical | Metastinderivat und seine verwendung |
| SMT201700131T1 (it) | 2008-07-30 | 2017-05-08 | Takeda Pharmaceuticals Co | Derivato di metastina e suo uso |
| EP2340047A1 (de) * | 2008-09-19 | 2011-07-06 | Nektar Therapeutics | Polymerkonjugate von kiss1-peptiden |
| EP2898900B1 (de) | 2008-09-19 | 2017-11-15 | Nektar Therapeutics | Polymerkonjugate von Ziconotid |
| US8716228B2 (en) | 2009-05-27 | 2014-05-06 | Yeda Research And Development Co. Ltd. | GPR54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities |
| EP2873422A4 (de) | 2012-07-10 | 2015-12-30 | Takeda Pharmaceutical | Pharmazeutische zubereitung zur injektion |
| TWI810193B (zh) | 2017-07-05 | 2023-08-01 | 大陸商尚華醫藥科技（江西）有限公司 | 一種Kiss1肽類化合物、其應用及含其的組合物 |
| CN109212217B (zh) * | 2018-11-07 | 2021-09-10 | 李玉民 | 基于amy1a蛋白胃癌检测试剂盒及其使用方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436155A (en) * | 1991-12-31 | 1995-07-25 | Arch Development Corporation | Isolated DNA encoding a somatostatin receptor |
| US6114139A (en) | 1994-08-11 | 2000-09-05 | Takeda Chemical Industries, Ltd. | G-protein coupled receptor protein and a DNA encoding the receptor |
| AU7399296A (en) | 1995-10-11 | 1997-04-30 | Penn State Research Foundation, The | A metastasis suppressor gene |
| US6010877A (en) | 1997-01-10 | 2000-01-04 | Smithkline Beecham Corporation | cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
| US5851798A (en) | 1997-01-27 | 1998-12-22 | Smithkline Beecham Corporation | Nucleic acid encoding human GPR14 receptor |
| CA2283299A1 (en) | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| US6420526B1 (en) * | 1997-03-07 | 2002-07-16 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| WO2000050563A2 (en) | 1999-02-24 | 2000-08-31 | Merck & Co., Inc. | G protein-coupled receptor resembling galanin receptors |
| US20020077469A1 (en) * | 1999-03-10 | 2002-06-20 | Borowsky Beth E. | DNA encoding orphan SNORF11 receptor |
| WO2004080479A1 (ja) * | 2003-03-12 | 2004-09-23 | Takeda Pharmaceutical Company Limited | 性腺機能改善剤 |
-
1999
- 1999-09-29 JP JP27622599A patent/JP4486187B2/ja not_active Expired - Fee Related
- 1999-10-26 IL IL14242899A patent/IL142428A0/xx unknown
- 1999-10-26 CA CA002347294A patent/CA2347294A1/en not_active Abandoned
- 1999-10-26 NZ NZ510977A patent/NZ510977A/xx unknown
- 1999-10-26 EP EP99949421A patent/EP1126028B1/de not_active Expired - Lifetime
- 1999-10-26 BR BR9914835-8A patent/BR9914835A/pt not_active IP Right Cessation
- 1999-10-26 PL PL99347553A patent/PL347553A1/xx not_active Application Discontinuation
- 1999-10-26 KR KR1020017005344A patent/KR20010085974A/ko not_active Withdrawn
- 1999-10-26 US US09/830,428 patent/US6699965B1/en not_active Expired - Fee Related
- 1999-10-26 SK SK550-2001A patent/SK5502001A3/sk unknown
- 1999-10-26 AU AU62306/99A patent/AU6230699A/en not_active Abandoned
- 1999-10-26 WO PCT/JP1999/005905 patent/WO2000024890A1/ja not_active Ceased
- 1999-10-26 CZ CZ20011358A patent/CZ20011358A3/cs unknown
- 1999-10-26 AT AT99949421T patent/ATE394485T1/de not_active IP Right Cessation
- 1999-10-26 HU HU0104937A patent/HUP0104937A2/hu unknown
- 1999-10-26 CN CN99812722A patent/CN1324405A/zh active Pending
- 1999-10-26 DE DE69938666T patent/DE69938666D1/de not_active Expired - Lifetime
- 1999-10-27 ID IDW20010936A patent/ID28288A/id unknown
-
2001
- 2001-04-26 NO NO20012059A patent/NO20012059L/no not_active Application Discontinuation
-
2004
- 2004-02-05 US US10/771,417 patent/US7314754B2/en not_active Expired - Fee Related
-
2007
- 2007-10-24 US US11/976,414 patent/US7608409B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2347294A1 (en) | 2000-05-04 |
| EP1126028B1 (de) | 2008-05-07 |
| PL347553A1 (en) | 2002-04-08 |
| CN1324405A (zh) | 2001-11-28 |
| EP1126028A4 (de) | 2002-11-27 |
| KR20010085974A (ko) | 2001-09-07 |
| WO2000024890A1 (en) | 2000-05-04 |
| NO20012059D0 (no) | 2001-04-26 |
| US7608409B2 (en) | 2009-10-27 |
| BR9914835A (pt) | 2002-06-18 |
| HUP0104937A2 (hu) | 2002-04-29 |
| ID28288A (id) | 2001-05-10 |
| US20040180407A1 (en) | 2004-09-16 |
| EP1126028A1 (de) | 2001-08-22 |
| IL142428A0 (en) | 2002-03-10 |
| JP4486187B2 (ja) | 2010-06-23 |
| AU6230699A (en) | 2000-05-15 |
| SK5502001A3 (en) | 2002-01-07 |
| US6699965B1 (en) | 2004-03-02 |
| CZ20011358A3 (cs) | 2001-08-15 |
| US7314754B2 (en) | 2008-01-01 |
| JP2000312590A (ja) | 2000-11-14 |
| NZ510977A (en) | 2002-10-25 |
| US20080131976A1 (en) | 2008-06-05 |
| NO20012059L (no) | 2001-06-26 |
| DE69938666D1 (de) | 2008-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE394485T1 (de) | Neue g protein-gekoppelte rezeptor proteine, dnas davon und liganden für diese | |
| Götz et al. | Neurotrophin-6 is a new member of the nerve growth factor family | |
| JENSEN et al. | Binding of A β to α-and β-synucleins: identification of segments in α-synuclein/NAC precursor that bind A β and NAC | |
| PT868519E (pt) | Diagnostico e tratamento de disturbios relacionados com aur-1 e/ou aur-2 | |
| DK0530265T3 (da) | DNA kodende for humane 5-HT1D-receptorer og anvendelser deraf | |
| ATE302278T1 (de) | Diagnose und behandlung von aur1 und/oder aur2 verwandten erkrankungen | |
| ATE189607T1 (de) | Dna codierend für einen menschlichen neuropeptid y/peptid yy/pankreaspolypeptid-rezeptor (y4) und seine verwendung | |
| ATE415631T1 (de) | AFFINITÄTSSCREENING MITTELS BIBLIOTHEKEN DES TYPS ßEINE-VERBINDUNG-PRO-KÜGELCHENß | |
| DE69938183D1 (de) | Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff | |
| BR0309638A (pt) | Polipeptìdeo, molécula de ácido nucleico purificada, vetor, célula hospedeira, ligando, composto, método de diagnóstico de uma doença em um paciente, uso de um polipeptìdeo, composição farmacêutica, composição de vacina, métodos de tratamento de uma doença em um paciente, de monitoração do tratamento terapêutico de doença em um paciente, e de identificação de um composto que é eficaz no tratamento e/ou no diagnóstico de doença, kit, animal não humano knockout ou transgênico, e, método para a seleção de um composto eficaz para o tratamento de doença | |
| MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
| DE69233496D1 (de) | Dna kodierend für den menschlichen 5-ht 1e-rezeptor und seine verwendungen | |
| DK0948604T3 (da) | Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet | |
| ATE547536T1 (de) | Lmna-gen und seine beteiligung an progeria hutchinson-gilford (hgps) und arteriosklerose | |
| DE602005019495D1 (de) | Ligand für den Formylpeptidrezeptorähnlichen- 2 (FPRL2) G Protein gekoppelten Rezeptor und dessen Anwendung | |
| EP0960937A4 (de) | Neues semaphorin-gen: semaphorin y | |
| DE69731845D1 (de) | Verfahren zum nachweis von protein s | |
| DE69925116D1 (de) | Neue, physiologisch aktive peptide und ihre verwendung. | |
| ATE350398T1 (de) | Protein s polypeptide und deren verwendungen | |
| EP2128257A3 (de) | Mutationen des parkin-gens, zusammensetzungen, verfahren und verwendungen | |
| WO2002018434A3 (en) | Proteins related to schizophrenia and uses thereof | |
| WO2003019197A3 (en) | Diabetic model | |
| WO2003025197A3 (en) | Mutant sh3-binding protein compositions and methods | |
| DE602004023493D1 (de) | Neues screening-verfahren | |
| RU2002107205A (ru) | Диагностика риска развития алкоголизма у человека |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |